News
- 2021.11.15 OTHER Toward development of cell therapy for renal diseases using iPS cells -Joint research on the development of monitoring methods for the quality and manufacturing processes of nephron progenitor cells-
- 2021.10.22 OTHER CiRA Foundation Activity Report Vol.2
- 2021.08.27 EVENT&SEMINARS Webinar for researchers
- 2021.08.12 OTHER Appointment of Shinya Yamanaka, Representative Director of CiRA Foundation, as the chair the Scientific Advisory Board of Orizuru Therapeutics Inc.
- 2021.08.05 RESEARCHES Free provision of iPS cells made from 6 COVID-19 convalescent patients
-
2021.06.01
RESEARCHES
First shipment of the iPS cell stock to an overseas partner
-
2021.05.19
EVENT&SEMINARS
Report : 1st Anniversary Activity Video Event
- 2021.05.19 RESEARCHES Provision of HLA-homozygous iPS cellｓ to Novo Nordisk
- 2021.05.18 RESEARCHES Platelets derived using the CiRA Foundation iPS Cell Stock enter an industry-led clinical trial
- 2021.05.10 RESEARCHES CiRA Foundation's First International Provision of HLA-homozygous iPS cell stock to CHA University in Korea